The m6A-regulation and single cell effect pattern in sunitinib resistance on clear cell renal cell carcinoma: Identification and validation of targets

被引:0
|
作者
Deng, Yanxi [1 ]
Wang, Fang [1 ]
Wu, Xinhui [2 ]
Du, Kangming [3 ]
Yang, Qing [3 ]
Xia, Ting [2 ,4 ]
机构
[1] Hosp Chengdu Univ Tradit Chinese Med, Clin Lab, Chengdu, Sichuan, Peoples R China
[2] Hosp Chengdu Univ Tradit Chinese Med, Chengdu, Sichuan, Peoples R China
[3] Hosp Chengdu Univ Tradit Chinese Med, Dept Cardiothorac Surg, Chengdu, Sichuan, Peoples R China
[4] Chengdu Univ Tradit Chinese Med, Chengdu, Sichuan, Peoples R China
关键词
epigenetic; sunitinib; ccRCC; MX2; biological; CANCER; IFITM1; PROMOTES;
D O I
10.3389/fphar.2023.1131610
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Sunitinib is the main target drug for clear cell renal cell carcinoma. However, the effect of sunitinib is often limited by acquired drug resistance.Methods: The open-accessed data used in this study were obtained from different online public databases, which were analyzed using the R software. The RNA level of specific genes was detected using quantitative Real-Time PCR. Sunitinib-resistant cell lines were constructed based on protocol get from the previous study. Colony formation and Cell Counting Kit-8 assays were applied to detect cell proliferation ability.Results: In this study, through publicly available data and high-quality analysis, we deeply explored the potential biological mechanisms that affect the resistance of sunitinib. Detailed, data from GSE64052, GSE76068 and The Cancer Genome Atlas were extracted. We identified the IFITM1, IL6, MX2, PCOLCE2, RSAD2 and SLC2A3 were associated with sunitinib resistance. Single-cell analysis, prognosis analysis and m6A regulatory network were conducted to investigate their role. Moreover, the MX2 was selected for further analysis, including its biological role and effect on the ccRCC microenvironment. Interestingly, we noticed that MX2 might be an immune-related gene that could affect the response rate of immunotherapy. Then, in vitro experiments validated the overexpression of MX2 in sunitinib-resistance cells. Colony formation assay indicated that the knockdown of MX2 could remarkably inhibit the proliferation ability of 786-O-Res and Caki-1-Res when exposed to sunitinib.Conclusion: In summary, through publicly available data and high-quality analysis, we deeply explored the potential biological mechanisms that affect the resistance of sunitinib. MX2 was selected for further analysis, including its biological role and effect on the ccRCC microenvironment. Finally, in vitro experiments were used to validate its role in ccRCC.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Identification of miRNAs and Their Target Genes Associated with Sunitinib Resistance in Clear Cell Renal Cell Carcinoma Patients
    Armesto, Maria
    Nemours, Stephane
    Arestin, Maria
    Bernal, Iraide
    Solano-Iturri, Jon Danel
    Manrique, Manuel
    Basterretxea, Laura
    Larrinaga, Gorka
    Angulo, Javier C.
    Lecumberri, David
    Iturregui, Ane Miren
    Lopez, Jose I.
    Lawrie, Charles H.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (13)
  • [2] Molecular profile of sunitinib resistance in clear-cell renal cell carcinoma
    Torras, Oscar Reig
    Marin-Aguilera, Mercedes
    Jimenez, Natalia
    Laia, Pare
    Galvan, Patricia
    Mallofre, Carme
    Prat, Aleix
    Mellado, Begona
    CANCER RESEARCH, 2017, 77
  • [3] Histological heterogeneity contributes to sunitinib resistance in clear cell renal cell carcinoma
    Lichner, Zsuzsanna
    Saleeb, Rola
    Butz, Henriett
    Nofech-Mozes, Roy
    Riad, Sara
    Farag, Mina
    Kapus, Andras
    Yousef, George
    CANCER RESEARCH, 2017, 77
  • [4] Identification of MX2 as a Novel Prognostic Biomarker for Sunitinib Resistance in Clear Cell Renal Cell Carcinoma
    Wei, Yuang
    Chen, Xinglin
    Ren, Xiaohan
    Wang, Bao
    Zhang, Qian
    Bu, Hengtao
    Qian, Jian
    Shao, Pengfei
    FRONTIERS IN GENETICS, 2021, 12
  • [5] miR-96-5p targets PTEN to mediate sunitinib resistance in clear cell renal cell carcinoma
    Park, Sang Eun
    Kim, Wonju
    Hong, Ji-Ye
    Kang, Dayeon
    Park, Seulki
    Suh, Jungyo
    You, Dalsan
    Park, Yun-Yong
    Suh, Nayoung
    Hwang, Jung Jin
    Kim, Choung-Soo
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [6] Intrinsic resistance to sunitinib in clear cell renal cell carcinoma: A gene expression analysis
    Reig, O.
    Marin-Aguilera, M.
    Lozano, J. J.
    Gonzalez, B.
    Mallofre, C.
    Campayo, M.
    Gascon, P.
    Mellado, B.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S167 - S167
  • [7] Impact of sunitinib resistance on clear cell renal cell carcinoma therapeutic sensitivity in vitro
    Ghosh, Susmita
    Garige, Mamatha
    Haggerty, Patrick R.
    Norris, Alexis
    Chou, Chao-Kai
    Wu, Wells W.
    Shen, Rong-Fong
    Sourbier, Carole
    CELL CYCLE, 2024, 23 (01) : 43 - 55
  • [8] Identification and validation of m6A-associated ferroptosis genes in renal clear cell carcinoma
    Pang, Shuo
    Zhao, Shuo
    Dongye, Yuxi
    Fan, Yidong
    Liu, Jikai
    CELL BIOLOGY INTERNATIONAL, 2024, 48 (06) : 777 - 794
  • [9] miR-96-5p targets PTEN to mediate sunitinib resistance in clear cell renal cell carcinoma
    Sang Eun Park
    Wonju Kim
    Ji-Ye Hong
    Dayeon Kang
    Seulki Park
    Jungyo Suh
    Dalsan You
    Yun-Yong Park
    Nayoung Suh
    Jung Jin Hwang
    Choung-Soo Kim
    Scientific Reports, 12
  • [10] Blocking stanniocalcin 2 reduces sunitinib resistance in clear cell renal cell carcinoma
    Qin, Zhen-Qian
    Li, Kong-Dong
    Chu, He-Zhen
    Yuan, Xue-Feng
    Shi, Hai-Feng
    Gu, Jie
    Xie, Yi-Min
    NEOPLASMA, 2022, 69 (01) : 145 - 154